首页> 外文会议>Conference on lasers in surgery: Advanced characterization, therapeutics, and systems >High Power (80w) KTP Laser Vaporization of the Prostate in the Management of Urinary Retention - Long Term Follow-Up
【24h】

High Power (80w) KTP Laser Vaporization of the Prostate in the Management of Urinary Retention - Long Term Follow-Up

机译:高功率(80W)KTP激光蒸发前列腺在尿潴留管理中 - 长期随访

获取原文

摘要

Introduction and Objectives: We have previously reported the use of high-powered photoselective vaporization of the prostate (PVP) for patients in urinary retention due to benign prostatic hyperplasia (BPH). PVP is a relatively new treatment for bladder outlet obstruction due to BPH, using laser energy to vaporize obstructing prostatic tissue. This study investigates the long-term follow up of patients treated with PVP for urinary retention. Materials and Methods: All participants signed informed consent, and were treated with high power 80 W quasi-continuous wave potassium-titanyl-phosphate (KTP) laser. Ten patients underwent the procedure from December 2001 until the present. One patient was excluded from the study for failure to return for follow-up. Mean patient follow-up was nine months, maximum of twelve months. Results: The mean pre-operative gland size by trans-rectal ultrasound was 48 grams. Mean utethral length was 3.2 cm. Mean laser time was 48.2 minutes and the mean energy usage was 82.2 kJoules. There were no peri-operative complications such as sepsis or measurable postoperative bleeding. The preoperative AUA Symptom Score (AUASS) decreased from a mean of 22.6 preoperatively to 17 at nine months postoperatively (p = 0.032). The Quality of Life Score (QOL) decreased from 4.6 preoperatively to 3.25 at 12 months postoperatively (p = 0.26). The maximum urine flow rate increased from a mean of 7.7 cc/sec preoperatively to 14.5 cc/sec at six months follow-up (p = 0.03). Conclusions: This follow-up study suggests that HP-KTP has a durable response in patients treated specifically for retention. It significantly improved urine flow rate and symptom score, and had a trend towards improvement in subjective quality of life. HP-KTP prostatectomy should be considered in treating patients in retention, especially those with significant co-morbidities or taking anticoagulation.
机译:介绍和目标:我们之前报道过使用前列腺(PVP)的高功率光电蒸发,患者因良性前列腺增生(BPH)而尿潴留。 PVP由于BPH引起的膀胱出口梗阻的一个相对较新的处理,使用激光能量来蒸发阻碍前列腺组织。本研究调查了PVP治疗尿潴留的长期随访。材料和方法:所有参与者签署了知情同意,并用高功率80 W准连续波钾 - 磷酸钛 - 磷酸酯(KTP)激光处理。 10名患者从2001年12月之前完成的程序直到现在。一名患者被排除在研究中,未能返回随访。平均患者随访九​​个月,最多12个月。结果:通过反肠超声的平均术前腺体尺寸为48克。平均犹太人长度为3.2厘米。平均激光时间为48.2分钟,平均能量使用量为82.2 kjoules。没有脓血病并发症,如败血症或术后术语。术前Aua症状评分(AuAss)从术前从术前从22.6的平均值减少到术前达到17个月(P = 0.032)。术后12个月,生命评分(QOL)的质量从术前从4.6点降低(P = 0.26)。在六个月随访时,最大尿液流量从术前从7.7cc / sec的平均值增加到14.5cc / sec(p = 0.03)。结论:这种后续研究表明,HP-KTP对专门用于保留的患者具有持久的反应。它显着提高了尿液流速和症状评分,并具有改善主观生活质量的趋势。应考虑HP-KTP前列腺切除术治疗保留患者,尤其是具有重要的持续生命性或服用抗凝血的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号